MedTrace Logo

Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application

NCT00621114 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2025-03-13

No results posted yet for this study

Summary

The clinical study aims at providing data on antimicrobial efficiency and a supposed additional preventive effect on catheter-related infections of a catheter with antibacterial surface coating in comparison to standard catheters without coating.

Conditions

  • Hemodialysis

Interventions

DEVICE

GamCath® central venous catheter

Choice of central venous catheter type

DEVICE

GamCath Dolphin® Protect central venous catheter

Choice of central venous catheter type

Sponsors & Collaborators

  • Gambro Dialysatoren GmbH

    collaborator INDUSTRY

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vantive Health LLC

    lead INDUSTRY

Principal Investigators

  • Teut Risler, Prof. Dr. · Universitaetsklinikum Tuebingen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00621114 on ClinicalTrials.gov